Literature DB >> 10677335

Application and interpretation of transmission/disequilibrium tests: transmission of HLA-DQ haplotypes to unaffected siblings in 526 families with type 1 diabetes.

B A Lie1, K S Ronningen, H E Akselsen, E Thorsby, D E Undlien.   

Abstract

It is widely believed that, if a genetic marker shows a transmission distortion in patients by the transmission/disequilibrium test (TDT), then a transmission distortion in healthy siblings would be seen in the opposite direction. This is also the case in a complex disease. Furthermore, it has been suggested that replacing the McNemar statistics of the TDT with a test of heterogeneity between transmissions to affected and unaffected children could increase the power to detect disease association. To test these two hypotheses empirically, we analyzed the transmission of HLA-DQA1-DQB1 haplotypes in 526 Norwegian families with type 1 diabetic children and healthy siblings, since some DQA1-DQB1 haplotypes represent major genetic risk factors for type 1 diabetes. Despite the strong positive and negative disease associations with particular DQ haplotypes, we observed no significant deviation from 50% for transmission to healthy siblings. This could be explained by the low penetrance of susceptibility alleles, together with the fact that IDDM loci also harbor strongly protective alleles that can override the risk contributed by other loci. Our results suggest that, in genetically complex diseases, detectable distortion in transmission to healthy siblings should not be expected. Furthermore, the original TDT seems more powerful than a heterogeneity test.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10677335      PMCID: PMC1288128          DOI: 10.1086/302780

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  21 in total

Review 1.  A protective role of the environment in the development of type 1 diabetes?

Authors:  J A Todd
Journal:  Diabet Med       Date:  1991-12       Impact factor: 4.359

Review 2.  Susceptibility to type I diabetes: HLA-DQ and DR revisited.

Authors:  J X She
Journal:  Immunol Today       Date:  1996-07

3.  The future of genetic studies of complex human diseases.

Authors:  N Risch; K Merikangas
Journal:  Science       Date:  1996-09-13       Impact factor: 47.728

4.  An extended transmission/disequilibrium test (TDT) for multi-allele marker loci.

Authors:  P C Sham; D Curtis
Journal:  Ann Hum Genet       Date:  1995-07       Impact factor: 1.670

5.  No difference in the parental origin of susceptibility HLA class II haplotypes among Norwegian patients with insulin-dependent diabetes mellitus.

Authors:  D E Undlien; H E Akselsen; G Joner; K Dahl-Jorgensen; O Aagenaes; O Sovik; E Thorsby; K S Rønningen
Journal:  Am J Hum Genet       Date:  1995-12       Impact factor: 11.025

6.  The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene.

Authors:  B A Lie; J A Todd; F Pociot; J Nerup; H E Akselsen; G Joner; K Dahl-Jørgensen; K S Rønningen; E Thorsby; D E Undlien
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

7.  A genome-wide search for human type 1 diabetes susceptibility genes.

Authors:  J L Davies; Y Kawaguchi; S T Bennett; J B Copeman; H J Cordell; L E Pritchard; P W Reed; S C Gough; S C Jenkins; S M Palmer
Journal:  Nature       Date:  1994-09-08       Impact factor: 49.962

8.  Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus.

Authors:  S T Bennett; A M Lucassen; S C Gough; E E Powell; D E Undlien; L E Pritchard; M E Merriman; Y Kawaguchi; M J Dronsfield; F Pociot
Journal:  Nat Genet       Date:  1995-03       Impact factor: 38.330

9.  Insulin gene region-encoded susceptibility to IDDM maps upstream of the insulin gene.

Authors:  D E Undlien; S T Bennett; J A Todd; H E Akselsen; I Ikäheimo; H Reijonen; M Knip; E Thorsby; K S Rønningen
Journal:  Diabetes       Date:  1995-06       Impact factor: 9.461

10.  Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33.

Authors:  J B Copeman; F Cucca; C M Hearne; R J Cornall; P W Reed; K S Rønningen; D E Undlien; L Nisticò; R Buzzetti; R Tosi
Journal:  Nat Genet       Date:  1995-01       Impact factor: 38.330

View more
  6 in total

Review 1.  The anti-insulin trimolecular complex in type 1 diabetes.

Authors:  Aaron W Michels; Maki Nakayama
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-08       Impact factor: 3.243

2.  Macrophage scavenger receptor 1 (Msr1, SR-A) influences B cell autoimmunity by regulating soluble autoantigen concentration.

Authors:  Stefanie Haasken; Jennifer L Auger; Justin J Taylor; Patricia M Hobday; Brian D Goudy; Philip J Titcombe; Daniel L Mueller; Bryce A Binstadt
Journal:  J Immunol       Date:  2013-06-21       Impact factor: 5.422

Review 3.  Immunologic endocrine disorders.

Authors:  Aaron W Michels; George S Eisenbarth
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

4.  The role of HLA genes in familial spondyloarthropathy: a comprehensive study of 70 multiplex families.

Authors:  R Said-Nahal; C Miceli-Richard; C Gautreau; R Tamouza; N Borot; R Porcher; D Charron; M Dougados; M Breban
Journal:  Ann Rheum Dis       Date:  2002-03       Impact factor: 19.103

5.  The same systemic autoimmune disease provokes arthritis and endocarditis via distinct mechanisms.

Authors:  Bryce A Binstadt; Jennifer L Hebert; Adriana Ortiz-Lopez; Roderick Bronson; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-15       Impact factor: 11.205

6.  Impact of diabetes susceptibility loci on progression from pre-diabetes to diabetes in at-risk individuals of the diabetes prevention trial-type 1 (DPT-1).

Authors:  Vincent Butty; Christopher Campbell; Diane Mathis; Christophe Benoist
Journal:  Diabetes       Date:  2008-06-12       Impact factor: 9.461

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.